| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 6 |
| 1 | NATALIZUMAB | 4 |
| 2 | RITUXIMAB | 4 |
| 3 | ADALIMUMAB-AATY | 3 |
| 4 | ADALIMUMAB-ADAZ | 3 |
| 5 | ADALIMUMAB-FKJP | 3 |
| 6 | CYCLOPHOSPHAMIDE | 2 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 9 | FLUDARABINE PHOSPHATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| 1 | CALCIFEDIOL | 1 | 0.0004 |
| 2 | DEFLAZACORT | 1 | 0.0004 |
| 3 | ENTECAVIR | 1 | 0.0001 |
| 4 | GOLIMUMAB | 1 | 0.0001 |
| 5 | ADALIMUMAB-FKJP | 3 | 0.0001 |
| 6 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 7 | ADALIMUMAB-AATY | 3 | 0.0001 |
| 8 | ADALIMUMAB-ADAZ | 3 | 0.0001 |
| 9 | ALEMTUZUMAB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 1 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 3 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 4 | 0.0000 |
| 8 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |